- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Nicholas Robert: Lag Time Between a Drug Approval, Availability in EMRs Can Impact Patient Care
Nicholas Robert, MD, medical director of Data, Evidence & Insights, McKesson Life Sciences, explains the impact of lag time between a drug's approval and its availability for use in the electronic medical record (EMR).
Nicholas Robert, MD, medical director of Data, Evidence & Insights, McKesson Life Sciences, explains the impact of lag time between a drug's approval and its availability for use in the electronic medical record (EMR).
Transcript
How can the lag time between a drug’s approval and the availability of the drug in the electronic health record for a physician to order impact patient care?
That’s something you could imagine: if there is a significant delay between a new regimen, and the only way to use a new regimen is through the EMR, those patients are not going to be treated with that new regimen. That was really the impetus for us to look at our own data and see how long that took because although we have not measured it, that’s something certainly something we could look at, which is what would happen, what is the advantage of getting new treatments in, assuming the new treatments are better treatments, which is the case. Obviously, the sooner you get the new treatment in the better chance you have on having an impact on patient care. So, it would be nice to look at that ourselves, and I think that might be something hopefully we will present at the next ISPOR.
Tech Advances for Ocular Conditions Could Revolutionize Care
March 5th 2025Advancements in ocular technology, teleretinal imaging, and low-vision aids, including artificial intelligence-powered smart glasses, were highlighted in research posters at the Southeastern Congress of Optometry 2025.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Advancing Care for Dry Eye and Corneal Conditions
March 1st 2025Advancements in dry eye care focus on improvements seen in patients treated with cyclosporine 0.09% following inadequate responses at a lower dose, and customizable scleral lenses offer a nonsurgical option for Salzmann nodular degeneration, enhancing vision and comfort.
Read More
